PSMD14 and plasma cell myeloma: Similarly, other inhibitors targeting PSMD14 are also reported to stabilize proteasome substrates and block proliferation of multiple myeloma (MM) cells 44-47, including those resistant to proteasome inhibitor which is an effective therapy for patients with MM 48, 49.